Developing hamster models to study human adenoviruses
Official title: Task A09: Hamster Model for Human Adenovirus
Funded at Saint Louis University · NIH-11197723 · Data updated 2026-11-12
This study is working on improving hamster models to help us learn more about adenoviruses, which can cause infections in people, so we can find better treatments for those affected.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Saint Louis University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project start | September 13, 2024 |
| Project end | September 12, 2025 |
| Funding year | 2024 |
| Award (this year) | $400,773 |
| NIH project number | 75N93024D00019-0-759302400002-1 |
| Project ID | NIH-11197723 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research would be individuals affected by adenoviral infections or those at risk of such infections.
✕Less likely to help
Patients with conditions unrelated to adenoviral infections may not receive any benefit from this research.
What this research studies
This research focuses on creating and improving hamster models to better understand human adenoviruses, which are responsible for various infectious diseases. By using these models, researchers aim to evaluate potential treatments and countermeasures against adenoviral infections. Patients may benefit from advancements in therapeutic agents that could arise from this work, as it seeks to enhance our understanding of how these viruses affect humans and how to combat them effectively.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective treatments for adenoviral infections in humans.
How similar studies have gone: Previous research has shown success in using animal models to study infectious diseases, indicating that this approach has potential for meaningful advancements.
Where this research is happening
-
Saint Louis University
Saint Louis, United States Active
Researchers
- Principal investigator: Toth, Karoly — Saint Louis University
- Study coordinator: Toth, Karoly
Related research
Other NIH-funded projects on the same topics.
-
Selective Targeting of Nurr1 for Alzheimer’s Disease
A small study tests new brain-targeted compounds to help people with Alzheimer’s by reducing inflammation and protecting brain cells.
-
Understanding how TDP-43 clumps cause brain cell damage in dementia
A research team is studying how clumps of TDP-43 protein mess with brain cell functions in Alzheimer’s and related dementias, with the goal of identifying what goes wrong and where.
-
Encephalitogenic stem-like T cells in MS and its disease models
This grant explores a specific type of brain-accumulating T cell linked to multiple sclerosis and tests new analytical tools to understand them better.
-
Endothelial dysfunction in Alzheimer’s disease: a data-driven model for diagnosis and prognosis
This research explores brain blood vessel problems in people with Alzheimer’s to find new biomarkers that could help diagnose and predict progression.
-
How alcohol may damage the brain’s protective barrier and how to stop it
Researchers are studying how heavy drinking could weaken the brain’s shield by changing a signaling system called LPA in blood vessels of the brain, and whether blocking parts of this system could help.
-
A brain immune-cell receptor (GPR56) and its link to Alzheimer's
Testing whether changing activity of a microglial receptor called GPR56 can reduce Alzheimer's brain plaques and related damage in people with Alzheimer's disease.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.